272 related articles for article (PubMed ID: 29938323)
1. Co-infection: the outcome of Plasmodium infection differs according to the time of pre-existing helminth infection.
Salazar-Castañón VH; Juárez-Avelar I; Legorreta-Herrera M; Govezensky T; Rodriguez-Sosa M
Parasitol Res; 2018 Sep; 117(9):2767-2784. PubMed ID: 29938323
[TBL] [Abstract][Full Text] [Related]
2. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
Zheng W; Liu J; Meng DY; Hu XF; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor contributes to immunopathogenesis during
Salazar-Castañón VH; Juárez-Avelar I; Legorreta-Herrera M; Rodriguez-Sosa M
Front Cell Infect Microbiol; 2022; 12():968422. PubMed ID: 36093199
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.
Page KR; Jedlicka AE; Fakheri B; Noland GS; Kesavan AK; Scott AL; Kumar N; Manabe YC
Infect Immun; 2005 Dec; 73(12):8369-80. PubMed ID: 16299335
[TBL] [Abstract][Full Text] [Related]
5. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.
Singh RP; Kashiwamura S; Rao P; Okamura H; Mukherjee A; Chauhan VS
J Immunol; 2002 May; 168(9):4674-81. PubMed ID: 11971017
[TBL] [Abstract][Full Text] [Related]
6. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
Kobayashi F; Ishida H; Matsui T; Tsuji M
J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683
[TBL] [Abstract][Full Text] [Related]
7. Comparative histopathology of mice infected with the 17XL and 17XNL strains of Plasmodium yoelii.
Fu Y; Ding Y; Zhou TL; Ou QY; Xu WY
J Parasitol; 2012 Apr; 98(2):310-5. PubMed ID: 22017443
[TBL] [Abstract][Full Text] [Related]
8. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
[TBL] [Abstract][Full Text] [Related]
9. Efficient control of Plasmodium yoelii infection in BALB/c and C57BL/6 mice with pre-existing Strongyloides ratti infection.
Kolbaum J; Eschbach ML; Steeg C; Jacobs T; Fleischer B; Breloer M
Parasite Immunol; 2012 Jul; 34(7):388-93. PubMed ID: 22554071
[TBL] [Abstract][Full Text] [Related]
10. Differential response of antigen presenting cells from susceptible and resistant strains of mice to Taenia crassiceps infection.
Reyes JL; Terrazas CA; Vera-Arias L; Terrazas LI
Infect Genet Evol; 2009 Dec; 9(6):1115-27. PubMed ID: 19465163
[TBL] [Abstract][Full Text] [Related]
11. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
Keswani T; Bhattacharyya A
Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
[TBL] [Abstract][Full Text] [Related]
12. Characterization of immune responses to single or mixed infections with P. yoelii 17XL and P. chabaudi AS in different strains of mice.
Chen G; Feng H; Liu J; Qi ZM; Wu Y; Guo SY; Li DM; Wang JC; Cao YM
Parasitol Int; 2010 Sep; 59(3):400-6. PubMed ID: 20609420
[TBL] [Abstract][Full Text] [Related]
13. Caspase-12 deficiency enhances cytokine responses but does not protect against lethal Plasmodium yoelii 17XL infection.
Miu J; Saleh M; Stevenson MM
Parasite Immunol; 2010; 32(11-12):773-8. PubMed ID: 21086719
[TBL] [Abstract][Full Text] [Related]
14. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii.
Kobayashi F; Morii T; Matsui T; Fujino T; Watanabe Y; Weidanz WP; Tsuji M
Parasitol Res; 1996; 82(5):385-91. PubMed ID: 8738275
[TBL] [Abstract][Full Text] [Related]
15. Supplement of L-Arg improves protective immunity during early-stage Plasmodium yoelii 17XL infection.
Zhu X; Pan Y; Li Y; Cui L; Cao Y
Parasite Immunol; 2012; 34(8-9):412-20. PubMed ID: 22709481
[TBL] [Abstract][Full Text] [Related]
16. Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria
Imai T; Suzue K; Ngo-Thanh H; Ono S; Orita W; Suzuki H; Shimokawa C; Olia A; Obi S; Taniguchi T; Ishida H; Van Kaer L; Murata S; Tanaka K; Hisaeda H
Front Immunol; 2019; 10():2207. PubMed ID: 31608052
[TBL] [Abstract][Full Text] [Related]
17. Concurrent infection with Heligmosomoides polygyrus suppresses anti-Plasmodium yoelii protection partially by induction of CD4(+)CD25(+)Foxp3(+) Treg in mice.
Tetsutani K; Ishiwata K; Ishida H; Tu L; Torii M; Hamano S; Himeno K; Hisaeda H
Eur J Immunol; 2009 Oct; 39(10):2822-30. PubMed ID: 19728313
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide contributes to host resistance against experimental Taenia crassiceps cysticercosis.
Alonso-Trujillo J; Rivera-Montoya I; Rodríguez-Sosa M; Terrazas LI
Parasitol Res; 2007 May; 100(6):1341-50. PubMed ID: 17206501
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide Preconditioning Augments Phagocytosis of Malaria-Parasitized Red Blood Cells by Bone Marrow-Derived Macrophages in the Liver, Thereby Increasing the Murine Survival after Plasmodium yoelii Infection.
Ono T; Yamaguchi Y; Nakashima H; Nakashima M; Ishikiriyama T; Seki S; Kinoshita M
Infect Immun; 2021 Oct; 89(11):e0024921. PubMed ID: 34424755
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium yoelii blood-stage primes macrophage-mediated innate immune response through modulation of toll-like receptor signalling.
Fu Y; Ding Y; Zhou T; Fu X; Xu W
Malar J; 2012 Apr; 11():104. PubMed ID: 22463100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
